S&P 500

5.487,03

0,25%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
Protalix BioTherapeutics Inc (PLX)
Protalix BioTherapeutics Inc (PLX) Notícias

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:PLX

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
17/05/2024	18:05	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	AMEX:PLX	Protalix BioTherapeutics Inc
17/05/2024	18:00	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:PLX	Protalix BioTherapeutics Inc
10/05/2024	08:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:PLX	Protalix BioTherapeutics Inc
10/05/2024	07:59	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:PLX	Protalix BioTherapeutics Inc
02/01/2024	08:36	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:PLX	Protalix BioTherapeutics Inc
30/11/2023	06:00	GlobeNewswire Inc.	Levicept Appoints Eliot Forster as CEO	AMEX:PLX	Protalix BioTherapeutics Inc
31/10/2023	17:40	AllPennyStocks.com	Upcoming Earnings Release Paired With Price Target Raise Sends Stock Soaring	AMEX:PLX	Protalix BioTherapeutics Inc
20/10/2023	07:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:PLX	Protalix BioTherapeutics Inc
15/09/2023	17:45	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:PLX	Protalix BioTherapeutics Inc
06/09/2023	07:50	PR Newswire (US)	Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	AMEX:PLX	Protalix BioTherapeutics Inc
11/08/2023	17:31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	AMEX:PLX	Protalix BioTherapeutics Inc
07/07/2023	17:30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:PLX	Protalix BioTherapeutics Inc
29/06/2023	08:25	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:PLX	Protalix BioTherapeutics Inc
28/06/2023	17:30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	AMEX:PLX	Protalix BioTherapeutics Inc
18/05/2023	18:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	AMEX:PLX	Protalix BioTherapeutics Inc
02/05/2023	09:27	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	AMEX:PLX	Protalix BioTherapeutics Inc
01/05/2023	07:48	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	AMEX:PLX	Protalix BioTherapeutics Inc
27/02/2023	09:59	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	AMEX:PLX	Protalix BioTherapeutics Inc
27/02/2023	08:47	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:PLX	Protalix BioTherapeutics Inc
03/01/2023	08:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	AMEX:PLX	Protalix BioTherapeutics Inc
14/11/2022	09:08	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:PLX	Protalix BioTherapeutics Inc
09/09/2022	18:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:PLX	Protalix BioTherapeutics Inc
14/07/2022	17:32	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	AMEX:PLX	Protalix BioTherapeutics Inc
05/07/2022	17:31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:PLX	Protalix BioTherapeutics Inc
09/06/2022	15:53	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:PLX	Protalix BioTherapeutics Inc
02/05/2022	07:26	Edgar (US Regulatory)	Notice of Effectiveness (effect)	AMEX:PLX	Protalix BioTherapeutics Inc
20/04/2022	17:50	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	AMEX:PLX	Protalix BioTherapeutics Inc
23/10/2020	18:02	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	AMEX:PLX	Protalix BioTherapeutics Inc
14/08/2020	18:03	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	AMEX:PLX	Protalix BioTherapeutics Inc
01/06/2020	18:22	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	AMEX:PLX	Protalix BioTherapeutics Inc